Press Releases Takara Bio Inc.

Equities

4974

JP3460200003

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-23 am EDT			5-day change	1st Jan Change
1,036 ^JPY	-4.78%		-4.78%	-17.25%

May. 10	Takara Bio Inc. Proposes Dividend for the Fiscal Year Ending March 31, 2024, Effective June 24, 2024	CI
Mar. 18	Takara Bio Inc.(TSE:4974) dropped from FTSE All-World Index	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Takara Bio transforms single-cell landscape with new large-scale NGS profiling system for oncology biomarker discovery	Apr. 03	AQ
Acute Lymphocytic Leukemia Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2024	Feb. 22	AQ
Takara Bio's first-to-market large-scale single-cell NGS profiling technologies poised to revolutionize biomarker discovery	Feb. 06	AQ
Acute Lymphocytic Leukemia Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2023 (Updated)	Dec. 22	AQ
Takara Bio USA wins EU opposition hearing, revoking Jumpcode Genomics NGS library enrichment patent	Dec. 12	AQ
Takara Bio : Annual Report 2023	23-09-12	PU
Takara Bio : Financial Results Presentation (May 16, 2023)	23-05-29	PU
Takara Bio : Notice of the 21th Annual General Meeting of Shareholders	23-05-22	PU
Takara Bio : Consolidated Financial Statements for FY Ended March 31 2023	23-05-11	PU
Takara Bio : Financial Results Presentation (November 15, 2022)	22-11-24	PU
Takara Bio : Consolidated Financial Statements for the Second Quarter Ended September 30, 2022	22-11-10	PU
Takara Bio : Consolidated Financial Statements for the First Quarter Ended June 30, 2023	22-08-04	PU
Takara Bio : Corporate Governance Report	22-07-06	PU
Takara Bio : Consolidated Financial Statements for the Third Quarter Ended December 31, 2021	22-02-09	PU
Takara Bio : Financial Results Presentation (November 11, 2021)	21-12-13	PU
Takara Bio : Annual Report 2021	21-11-15	PU
Takara Bio : Supplements for Takara Bio Report 2021	21-11-15	PU
Consolidated Financial Statements for the Second Quarter Ended September 30, 2021 FY2022 (April 1, 2021 - March 31, 2022) [UNAUDITED]	21-11-09	PU
Takara Bio : Consolidated Financial Statements for the First Quarter Ended June 30, 2021 FY2022 (April 1, 2021 － June 30, 2021) 〔UNAUDITED〕	21-08-03	PU
Takara Bio : Consolidated Financial Statements for the Year Ended March 31, 2021 FY2021 (April 1, 2020 - March 31, 2021)	21-05-13	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Takara Bio Inc.

Equities

4974

JP3460200003

Press Releases

Filters